205 related articles for article (PubMed ID: 31862626)
1. Prion-like properties of assembled TDP-43.
Nonaka T; Hasegawa M
Curr Opin Neurobiol; 2020 Apr; 61():23-28. PubMed ID: 31862626
[TBL] [Abstract][Full Text] [Related]
2. [The Propagation Hypothesis of Prion-like Protein Agregates in Neurodegenerative Diseases].
Nonaka T
Brain Nerve; 2019 Nov; 71(11):1209-1214. PubMed ID: 31722306
[TBL] [Abstract][Full Text] [Related]
3. TDP-43 Prions.
Nonaka T; Hasegawa M
Cold Spring Harb Perspect Med; 2018 Mar; 8(3):. PubMed ID: 28108532
[TBL] [Abstract][Full Text] [Related]
4. The role of TDP-43 propagation in neurodegenerative diseases: integrating insights from clinical and experimental studies.
Jo M; Lee S; Jeon YM; Kim S; Kwon Y; Kim HJ
Exp Mol Med; 2020 Oct; 52(10):1652-1662. PubMed ID: 33051572
[TBL] [Abstract][Full Text] [Related]
5. [The Prion-like Mechanism in Neurodegenerative Diseases-Current Studies and Future Prospects].
Tarutani A; Hisanaga SI; Hasegawa M
Brain Nerve; 2016 Oct; 68(10):1197-1204. PubMed ID: 27703107
[TBL] [Abstract][Full Text] [Related]
6. Prion-like propagation of α-synuclein in neurodegenerative diseases.
Tarutani A; Hasegawa M
Prog Mol Biol Transl Sci; 2019; 168():323-348. PubMed ID: 31699325
[TBL] [Abstract][Full Text] [Related]
7. Ultrastructural and biochemical classification of pathogenic tau, α-synuclein and TDP-43.
Tarutani A; Adachi T; Akatsu H; Hashizume Y; Hasegawa K; Saito Y; Robinson AC; Mann DMA; Yoshida M; Murayama S; Hasegawa M
Acta Neuropathol; 2022 Jun; 143(6):613-640. PubMed ID: 35513543
[TBL] [Abstract][Full Text] [Related]
8. Experimental models of prion-like protein propagation.
Hasegawa M
Neuropathology; 2020 Oct; 40(5):460-466. PubMed ID: 32478452
[TBL] [Abstract][Full Text] [Related]
9. [Can prion-like propagation occur in neurodegenerative diseases?: in view of transmissible systemic amyloidosis].
Yoshida K; Higuchi K; Ikeda S
Brain Nerve; 2012 Jun; 64(6):665-74. PubMed ID: 22647474
[TBL] [Abstract][Full Text] [Related]
10. Molecular mechanisms of the co-deposition of multiple pathological proteins in neurodegenerative diseases.
Nonaka T; Masuda-Suzukake M; Hasegawa M
Neuropathology; 2018 Feb; 38(1):64-71. PubMed ID: 28948653
[TBL] [Abstract][Full Text] [Related]
11. Prion-like C-Terminal Domain of TDP-43 and α-Synuclein Interact Synergistically to Generate Neurotoxic Hybrid Fibrils.
Dhakal S; Wyant CE; George HE; Morgan SE; Rangachari V
J Mol Biol; 2021 May; 433(10):166953. PubMed ID: 33771571
[TBL] [Abstract][Full Text] [Related]
12. Prion-like mechanisms and potential therapeutic targets in neurodegenerative disorders.
Hasegawa M; Nonaka T; Masuda-Suzukake M
Pharmacol Ther; 2017 Apr; 172():22-33. PubMed ID: 27916654
[TBL] [Abstract][Full Text] [Related]
13. Like prions: the propagation of aggregated tau and α-synuclein in neurodegeneration.
Goedert M; Masuda-Suzukake M; Falcon B
Brain; 2017 Feb; 140(2):266-278. PubMed ID: 27658420
[TBL] [Abstract][Full Text] [Related]
14. Decoding the Cellular Trafficking of Prion-like Proteins in Neurodegenerative Diseases.
Hu C; Yan Y; Jin Y; Yang J; Xi Y; Zhong Z
Neurosci Bull; 2024 Feb; 40(2):241-254. PubMed ID: 37755677
[TBL] [Abstract][Full Text] [Related]
15. Phase Separation and Neurodegenerative Diseases: A Disturbance in the Force.
Zbinden A; Pérez-Berlanga M; De Rossi P; Polymenidou M
Dev Cell; 2020 Oct; 55(1):45-68. PubMed ID: 33049211
[TBL] [Abstract][Full Text] [Related]
16. Sorting out release, uptake and processing of alpha-synuclein during prion-like spread of pathology.
Tyson T; Steiner JA; Brundin P
J Neurochem; 2016 Oct; 139 Suppl 1(Suppl 1):275-289. PubMed ID: 26617280
[TBL] [Abstract][Full Text] [Related]
17. TDP-43 in amyotrophic lateral sclerosis - is it a prion disease?
Ludolph AC; Brettschneider J
Eur J Neurol; 2015 May; 22(5):753-61. PubMed ID: 25846565
[TBL] [Abstract][Full Text] [Related]
18. [Prion-like Propagation of Pathological α-Synuclein in Vivo].
Masuda-Suzukake M; Hasegawa M
Yakugaku Zasshi; 2019; 139(7):1007-1013. PubMed ID: 31257247
[TBL] [Abstract][Full Text] [Related]
19. On the role of the cellular prion protein in the uptake and signaling of pathological aggregates in neurodegenerative diseases.
Legname G; Scialò C
Prion; 2020 Dec; 14(1):257-270. PubMed ID: 33345731
[TBL] [Abstract][Full Text] [Related]
20. The role of crowded physiological environments in prion and prion-like protein aggregation.
Ma Q; Hu JY; Chen J; Liang Y
Int J Mol Sci; 2013 Oct; 14(11):21339-52. PubMed ID: 24284393
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
